Robotic surgery and liver transplantation:A single-center experience of 501 robotic donor hepatectomies

作     者：Maren Schulze Yasser Elsheikh Markus Ulrich Boehnert Yasir Alnemary Saleh Alabbad Dieter Clemens Broering Maren Schulze;Yasser Elsheikh;Markus Ulrich Boehnert;Yasir Alnemary;Saleh Alabbad;Dieter Clemens Broering

作者机构：Organ Transplant Center of ExcellenceKing Faisal Specialist Hospital&Research CentreP.O.Box 3354Riyadh 11211Saudi Arabia 

出 版 物：《Hepatobiliary & Pancreatic Diseases International》 (国际肝胆胰疾病杂志（英文版）)

年 卷 期：2022年第21卷第4期

页      面：334-339页

核心收录：

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

主　　题：Living liver donor Innovation Robotic donor surgery Donor safety Minimally invasive donor surgery 

摘      要：Background:Over the past two decades robotic surgery has been introduced to many areas including liver *** liver surgery is an alternative minimally invasive ***,moving on to the complexity of living donor hepatectomies,the advantages of robotic versus laparoscopic approach have convinced us to establish the robotic platform as a standard for living donor ***:From November 2018 to January 2022,501 fully robotic donor hepatectomies,including 177 left lateral donor lobes,112 full left lobes and 212 full right lobes were *** were donated to 296 adult recipients and 205 pediatric *** age,sex,body weight,body mass index(BMI),graft weight,graft to body weight ratio(GBWR),operative time,blood loss,first warm ischemic time,pain score,length of intensive care unit(ICU)stay and hospital stay,and complications were retrospectively analyzed based on a prospectively kept *** were evaluated for graft and patient survival,age,sex,BMI,body weight,model of end-stage liver disease score,blood loss,transfusions,operative time,cold ischemic time,length of hospital stay and ***:There was no donor *** cases needed to be converted to open *** median blood loss was 60 mL(range 20-800),median donor operative time was 6.77 h(range 2.93-11.53),median length of hospital stay was 4 days(range 2-22).Complication rate in donors classified following ClavienDindo was 6.4%(n=32)with one grade Ⅲ ***-year actual recipient overall survival was 91.4%;87.5% for adult recipients and 97.1% for pediatric ***-year actual graft overall survival was 90.6%;87.5% for adult recipients and 95.1% for pediatric ***-hospital mortality was 6%,9.1%(27/296)for adult recipients and 1.4%(3/205)for pediatric *** recipients’morbidity was 19.8%(n=99).Twenty-eight recipients(5.6%)had biliary and 22(4.4%)vascular ***(12.0%)recipients needed to